Gilead Sciences CDR (CAD Hedged) (GILD)

Gilead Sciences CDR (CAD Hedged) (GILD $30.45)
- $30.45 P/E (TTM): 398.42X Cap: $253.89B
- View GILD Profile
- View Questions on GILD

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Intuitive Surgical Inc. (ISRG $503.51)
- $503.51 P/E (TTM): 62.53X Cap: $178.81B
- View ISRG Profile
- View Questions on ISRG
Vertex Pharmaceuticals Incorporated (VRTX $496.83)
- $496.83 P/E (TTM): 31.46X Cap: $126.21B
- View VRTX Profile
- View Questions on VRTX
AbbVie Inc. (ABBV $232.08)
- $232.08 P/E (TTM): 175.18X Cap: $410.35B
- View ABBV Profile
- View Questions on ABBV
Johnson & Johnson (JNJ $248.43)
- $248.43 P/E (TTM): 22.29X Cap: $598.69B
- View JNJ Profile
- View Questions on JNJ
Eli Lilly and Company (LLY $1,051.99)
- $1,051.99 P/E (TTM): 46.12X Cap: $992.40B
- View LLY Profile
- View Questions on LLY
Merck & Company Inc. (MRK $123.82)
- $123.82 P/E (TTM): 16.37X Cap: $306.13B
- View MRK Profile
- View Questions on MRK
iShares Biotechnology ETF (IBB $175.37)
- $175.37 P/E (TTM): 20.63X Cap: $8.67B
- View IBB Profile
- View Questions on IBB
IDEXX Laboratories Inc. (IDXX $656.73)
- $656.73 P/E (TTM): 49.42X Cap: $52.29B
- View IDXX Profile
- View Questions on IDXX
Halozyme Therapeutics Inc. (HALO $69.53)
- $69.53 P/E (TTM): 14.87X Cap: $8.20B
- View HALO Profile
- View Questions on HALO
Incyte Corporation (INCY $101.27)
- $101.27 P/E (TTM): 15.73X Cap: $20.15B
- View INCY Profile
- View Questions on INCY
Catalyst Pharmaceuticals Inc. (CPRX $23.08)
- $23.08 P/E (TTM): 14.02X Cap: $2.81B
- View CPRX Profile
- View Questions on CPRX
Gilead Sciences CDR (CAD Hedged) (GILD $30.45)
- $30.45 P/E (TTM): 398.42X Cap: $253.89B
- View GILD Profile
- View Questions on GILD

Q: We have accumulated 11 healthcare stocks and 1 ETF, While LLY and ISRG are at half positions the rest are at initial 25% positions. Please advise [help!] us get to a more concentrated portfolio with a 3+ year horizon for reasonable opportunities in healthcare

Read Answer Asked by sam on January 13, 2026